Key Points
IperionX is a U.S. titanium company -- that files its financials in Australia.
IperionX lost $0.10 per share in the first half of fiscal 2026.
- 10 stocks we like better than IperionX ›
IperionX Limited (NASDAQ: IPX) stock tumbled 14.4% through 10:10 a.m. ET Thursday after reporting financial results for the first half of its fiscal 2026.
IperionX reported a $0.10 per share loss for the half, and no revenue.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
Introducing IperionX
IperionX is a bit of an odd duck. Although headquartered in North Carolina, and describing itself as "a leading American titanium metal and critical materials company," IperionX was originally incorporated in Australia -- and still files financials there. Its most recent filing, its "half year account" for the first half of fiscal 2026, ending Dec. 31, 2025, appeared there this morning.
The numbers weren't great.
IperionX spent $10.8 million on research and development in the first half, $3.3 million on exploration work, and $34.8 million in total -- but collected no revenue at all. Exchange rates mitigated the damage, but ultimately, IperionX ended losses of $0.10 per share -- worse than its $0.06 per share loss a year ago.
On the plus side, IperionX has $65.8 million in cash and equivalents, and incurred $31.1 million in capital expenditures. So IperionX still has enough cash to last it another year.
Is IperionX stock a buy?
IperionX did not provide guidance in its filing, but analysts polled by S&P Global Market Intelligence forecast the company will end this fiscal year with a loss of $0.07 per share. The good news here is twofold:
First, $0.07 is less than $0.10, so analysts are forecasting a profit in the second half of the fiscal year. Second, analysts forecast IperionX will be profitable for all of next year, fiscal 2027.
Still, the forecast profit is only $0.06 per share. On a $41 stock, that seems really expensive. IperionX is a sell for me.
Should you buy stock in IperionX right now?
Before you buy stock in IperionX, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and IperionX wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $511,735!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,140,464!*
Now, it’s worth noting Stock Advisor’s total average return is 946% — a market-crushing outperformance compared to 191% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of March 12, 2026.
Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
